Israel Reaffirms a Hard 30-Month PCT Deadline as Fees Shift
Israel’s 2026 patent fee schedule is now being applied in practice, and the change is broader than a routine tariff update. The filing fee, excess-claim fee and later renewal tranches now sit in clearer view at the start of the prosecution timeline, forcing applicants to think earlier about claim count, drafting scope and whether Israel is still a priority market at national-phase entry.
The more important message in July 2026 is procedural. Israel continues to apply a hard 30-month deadline for PCT national-phase entry, and that applies under both Article 22 and Article 39 routes. Recent operational uncertainty has not turned that rule into a de facto 31-month system. Rights can in principle be reinstated after a miss, but the remedy remains narrow in practice and should be treated as emergency relief, not ordinary docketing flexibility.
The fee reset changes when the real cost decision gets made
On paper, the new schedule looks straightforward: a filing fee, an excess-claim fee once the claim set becomes large, and renewal fees staged later in the life of the case. In practice, that clarity moves pressure upstream. Applicants now have less room to pretend that Israel can simply be “kept alive for later” without an earlier discussion about claim strategy, specification length, commercial relevance and expected prosecution depth.
That matters because Israel often sits in a second tier of national-phase decisions for global portfolios. It is important, but not always decided first. Once the fee structure becomes more visible, internal finance and business teams tend to ask harder questions sooner: Are we entering with a broad claim set? Do we expect to maintain the case through grant? Is the market or enforcement value strong enough to justify the path? A fee update can therefore reshape filing behavior even without any headline change in substantive patent law.
The 30-month deadline deserves its own docket, not a borrowed one
The practical problem is not that applicants do not know the rule exists. It is that many international teams still work from a blended memory of “30 or 31 months,” because several major jurisdictions have trained them to think that way. Israel does not fit comfortably inside that habit. For Israel, both the Article 22 and Article 39 national-phase routes point to 30 months from the priority date.
This is where docketing errors begin. Teams sometimes mix up curable formal defects with the core act of entering the national phase. A missing item may in some situations be corrected after a timely entry has already been made. That is very different from assuming there is a general extra month to decide, instruct counsel or pay later. For Israel, the entry deadline itself needs to be treated as a stand-alone control point, not as a date that can borrow comfort from 31-month jurisdictions.
Reinstatement exists, but it is not a planning tool
Israeli practice does leave room, in principle, for reinstatement of rights after a missed entry. That should not be misunderstood as a routine paid extension. The real issue is not whether a form can be filed after the deadline, but whether the applicant can credibly show that the miss occurred despite a system that was designed to avoid exactly that outcome. Once that becomes the question, the burden shifts quickly from paperwork to evidence.
This is why experienced filers treat reinstatement as a narrow safety valve. Explanations such as internal overload, confusion with a 31-month country or a vague reference to a difficult operating period rarely make a comfortable basis for risk management. By the time a reinstatement request is being discussed, the applicant is already arguing from a weakened position. The better discipline is to treat 30 months as a hard perimeter and keep reinstatement in the category of damage control, not optional timing management.
What applicants should change now
The most useful adjustment is operational, not doctrinal. Israel should be taken out of any generic “Europe and nearby markets” workflow and docketed separately with an earlier internal decision point. For cases that still need translation checks, ownership confirmation, an address for service in Israel or coordination with local counsel, compressing everything against the statutory deadline creates unnecessary exposure.
A better habit is to make the Israel call around month 28 or 29. By then, the business team should already know whether Israel remains strategically important, the claim package should be close to final, and budget ownership should be clear. That approach matters even more in periods of external disruption. The safest assumption is not that the Office may show flexibility, but that your own timetable should be stricter than the law requires.



